Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease

NCT00456859 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure, Chronic

Interventions

DRUG: Kremezin

Sponsor

Institute for Health Outcomes and Process Evaluation Reseach